Tafamidis Meglumine Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Tafamidis Meglumine Capsule (capsule) from Pfizer Inc. with status No longer listed by FDA. The shortage was first posted on Sep 29, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Pfizer Inc.
- Package NDC
- 0069-1975-40
- Dosage Form
- Capsule
- Presentation
- Vyndaqel, Capsule, 20 mg soft gelatin capsules; blister card (120 total capsules) (NDC 0069-1975-40)
- Initial Posting
- Sep 29, 2025